Literature DB >> 1560323

Modulation of infant formula fat profile alters the low-density lipoprotein/high-density lipoprotein ratio and plasma fatty acid distribution relative to those with breast-feeding.

K C Hayes1, A Pronczuk, R A Wood, D G Guy.   

Abstract

The effect of breast-feeding was compared with that of two fat-modified milk formulas in 45 infants (15 per group) studied by assessing body weight gain for 4 months and plasma lipids, lipoprotein profiles, fatty acid profiles of plasma and red blood cells, and plasma tocopherol status 3 months after birth. A saturated fat formula with coconut oil/soybean oil (COCO/SOY) had a fatty acid content and polyunsaturated/saturated ratio (P/S, 0.55) comparable with that of human milk fat (P/S, 0.39) and had the same fat energy content (50% kcal). The second formula, with corn oil/soybean oil (CORN/SOY), was highly unsaturated (P/S, 4.6), with only 35% kcal from fat. Energy intake and body weight gain were similar for all groups. Plasma total cholesterol, triglyceride, and phospholipid levels were significantly lower (greater than 20% on average) in infants fed the CORN/SOY formula than in infants fed either the COCO/SOY formula or human milk. Infants fed the CORN/SOY formula also had lower (25% to 35%) plasma low-density lipoprotein cholesterol and apolipoprotein B levels and low-density lipoprotein/high-density lipoprotein and apolipoprotein B/apolipoprotein A-I ratios. Plasma, red blood cell, and cholesteryl ester fatty acids from infants fed COCO/SOY contained less 18:1 and more 18:2; cholesterol esters in plasma from breast-fed infants had the highest 20:4n-6 levels. Plasma tocopherol levels were higher in infants consuming formulas. The presence of cholesterol in human milk appeared to expand the low-density lipoprotein pool and exert an "unfavorable" increase in the low-density lipoprotein/high-density lipoprotein ratio. Thus modulation of infant lipoproteins by changing dietary fat and cholesterol is feasible and in keeping with the known response in adults.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560323     DOI: 10.1016/s0022-3476(05)81244-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  The effect of alpha-linolenic acid and linoleic acid on the growth and development of formula-fed infants: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tuesday Udell; Robert A Gibson; Maria Makrides
Journal:  Lipids       Date:  2005-01       Impact factor: 1.880

Review 2.  Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.

Authors:  Tim Schindler; John Kh Sinn; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2016-10-28

3.  Milk Fat Globule structure & function; nanosciece comes to milk production.

Authors:  Nurit Argov; Danielle G Lemay; J Bruce German
Journal:  Trends Food Sci Technol       Date:  2008-12       Impact factor: 12.563

4.  Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patient.

Authors:  T L Alley; B A Gray; S H Lee; S W Scherer; L C Tsui; G S Tint; C A Williams; R Zori; M R Wallace
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

5.  High versus low medium chain triglyceride content of formula for promoting short-term growth of preterm infants.

Authors:  Laura Perretta; Laila Ouldibbat; James I Hagadorn; Heather L Brumberg
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

6.  Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons.

Authors:  Cara J Westmark
Journal:  Front Nutr       Date:  2017-01-18

7.  Infant Rhesus Macaque Brain α-Tocopherol Stereoisomer Profile Is Differentially Impacted by the Source of α-Tocopherol in Infant Formula.

Authors:  Matthew J Kuchan; Katherine M Ranard; Priyankar Dey; Sookyoung Jeon; Geoff Y Sasaki; Karen J Schimpf; Richard S Bruno; Martha Neuringer; John W Erdman
Journal:  J Nutr       Date:  2020-09-01       Impact factor: 4.687

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.